What is the catalog number for Dasatinib-13C415N2?

The catalog number for Dasatinib-13C415N2 is CS-T-103631.

What sizes are available for Dasatinib-13C415N2?

Dasatinib-13C415N2 is available in the following size(s): 1 Each.

Is Dasatinib-13C415N2 in stock?

Dasatinib-13C415N2 is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Dasatinib-13C415N2?

The safety data sheet for Dasatinib-13C415N2 is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-T-103631.

Dasatinib-13C415N2

Dasatinib-13C415N2 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Dasatinib. The product is supplied by Clearsynth under CAT No. CS-T-103631. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Isotope labelled Dasatinib (D193600), A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. It is a COVID19-related research product.

CAS Number

1107614-42-5

Synonyms

Dasatinib-13C415N2

Molecular Formula

C 1813 C 4 H 26 ClN 515 N 2 O 2 S

Molecular Weight

493.96

Additionnal Information

Dasatinib-13C415N2 is supplied with detailed characterization data compliant with regulatory guideline. Dasatinib-13C415N2 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Dasatinib.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Isotope labelled Dasatinib (D193600), A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. It is a COVID19-related research product.